✦ LIBER ✦

The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer

✍ Scribed by George Dranitsaris; William K. Evans; Debbie Milliken; Brent Zanke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of gefitinib (‘Iressa’) treatment

✍ Alain Gelibter; Anna Ceribelli; Camillo F. Pollera; Michele Milella; Luca Moscet 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 224 KB

Vindesine and high-dose cisplatin in the

✍ Fuks, Joachim Z. ;Patel, Halesh ;van Echo, David A. ;Hornedo, Javier ;Aisner, Jo 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB

Neoadjuvant and adjuvant therapy in the

✍ Michael T. Jaklitsch; Gary M. Strauss; David J. Sugarbaker 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 615 KB

Gemcitabine and carboplatin in the treat

✍ Chai-Hooi LEOW; Chong-Kin LIAM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Effect of the introduction of minimum le

✍ Hirokazu Watanabe; Hideo Kunitoh; Seiichiro Yamamoto; Shin Kawasaki; Akira Inoue 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Phase II study of the combination of vin

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Keigo Tominaga 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 169 KB